Knowledge base · Peer-reviewed

ScaleWiki.

Peer-reviewed manuscripts on the G-Rex® platform — one citable page per paper, curated so you find the evidence that moves your cell & gene therapy program forward.

487Manuscripts indexed
14Cell types
Live indexContinuously updated

Showing 12 of 530 resources

Publications B Cells G-Rex®10, G-Rex®100

Publication Date: May 12, 2010

SOP: D03.01.23 GENERATION OF EBV-TRANSFORMED CELL LINES (LYMPHOBLASTOID CELL LINES – LCL)

SOP D03.01.23 (Center for Cell & Gene Therapy GMP Facility) defines how GMP staff generate Epstein-Barr virus-transformed lymphoblastoid cell lines (LCLs) as stimulator cells for cytotoxic T-lymphocyte (CTL) production. Starting material: fresh or frozen PBMC from the stem cell donor (ETNA protocol) or the patient (ANGEL, ANGELA or SCAEBV protocols), with donor infectious disease testing within 30 days of collection. 5 × 10^6 PBMC are infected with 200 µl of B95-8 EBV supernatant in medium with 1 µg/ml cyclosporin A, plated in 96-well plates, then moved to 24-well plates and a 25 cm2 flask with acyclovir. LCLs may be expanded in GP40 and GP500 bioreactors (about 5 × 10^7 cells by day…

Download Now →

Author: Cliona Rooney, Catherine Bollard +2 more

Publications CTL Cells G-Rex®100M, G-Rex®10M, G-Rex®500M

Publication Date: April 1, 2010

Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex®)

Gas-permeable G-Rex® cultureware increased the output of Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs) compared with 24-well plates while cutting hands-on work. Activated CTLs seeded at 5 × 10^5 cells/cm² reached a median of 7.9 × 10^6/cm² after 3 days in the G-Rex®40 versus 1.8 × 10^6/cm² in plates, mainly through better cell survival rather than extra divisions. With an optimized feeder-to-CTL ratio, the 16-day process in G-Rex®40 then G-Rex®500 gave a median 6.5 × 10^8 cells, and splitting cultures extended growth to a median 5.07 × 10^9 cells by days 27 to 30. Phenotype, antigen specificity and cytolytic activity were unchanged. Producing 1 × 10^10 CTLs fell from abou…

Download Now →

Author: Juan F. Vera, Lara J. Brenner +9 more

Publications Other

Publication Date: August 1, 2009

PHARMACEUTICAL DEVELOPMENT Q8(R2)

ICH Q8(R2) sets out what a manufacturer should present in the Pharmaceutical Development section of a marketing application, with the aim of designing a quality product and a process that consistently delivers its intended performance. It stresses that the knowledge gained, not the volume of data, underpins science-based submissions. The annex describes quality by design: defining a quality target product profile, identifying critical quality attributes, assessing risk to link material attributes and process parameters to those attributes, and establishing a design space and a control strategy. Greater scientific understanding can support more flexible regulatory approaches, including rea…

Download Now →

Author: ICH Expert Working Group

Publications Other

Publication Date: January 1, 2006

Improved Islet Culture on Top of Gas-Permeable Membranes

Culturing pancreatic islets on top of gas-permeable silicone rubber membranes allowed a 20-fold increase in seeding density without loss of islet quality. Porcine and human islets were cultured in devices with 100 μm silicone rubber bottoms and compared with standard flasks at 200 IE/cm2 and 1 μl/IE. At 1000 to 4000 IE/cm2, gas-permeable culture gave similar fractional viability by oxygen consumption rate per DNA, higher viable tissue recovery (p=0.04), and 100% diabetes reversal in nude mice. In non-gas-permeable devices above 1000 IE/cm2, viability and recovery fell and diabetes was not reversed. Dilutions up to at least 4 μl/IE, media heights up to at least 4 cm, and 7 days without med…

Download Now →

Author: Klearchos K Papas, Bernhard J Hering +3 more

Literature T-Cells

Ready to Use Cytokines -Closed System

IL-15 proved necessary to sustain T-cell growth and IL-7 necessary to hold CCR7 expression, and cells did not expand at all when both cytokines were left out. Titrating IL-7 and IL-15 each at 0, 2.5, 5, 10 or 15 ng/mL shifted fold expansion and CD127 levels while leaving the CD45RA and CCR7 memory profile largely unchanged. Overdosing IL-15 lowered the memory marker CD127, most clearly on CD8+ T cells, whereas CD127 stayed stable across the IL-7 titration. On this basis Bio-Techne released GMP IL-2, IL-7, IL-15 and IL-21 in three ready-to-use formats: closed-system ProPak bags, process-sized single-use vials and liquid vials.

Scientific Posters G-Rex®500M-CS

G-Rex® and Heracell Vios Incubators and Cross Contamination Prevention

Closed System G-Rex® bioreactors held their sterile fluid path intact through at least fourteen days of full immersion in a challenge solution of Brevundimonas diminuta, a 0.3 to 0.6 micrometre motile gram-negative indicator organism, with no bacterial growth recovered from nutrient broth sampled from the test vessels. G-Rex® membrane material also passed viral penetration testing to ASTM F1671, with 32 test articles pressurised to 2.0 psig against a Phi-X174 bacteriophage suspension of at least 1.0 x 10^6/mL. Ten G-Rex® 500M-CS bioreactors incubated together in a Heracell Vios CR CO2 incubator still allowed recovery of temperature, CO2 and humidity within 10 minutes, uniformity of +/- 0.…

Download Now →

Author: Mary Kay Bates, Dan Fick +3 more

Videos

G-Rex® – Revolutionizing Cell Therapy Manufacturing

In this video you will learn how G-Rex® solve the limitations of flask and bag-based cell therapy manufacturing. By providing cells with uninterrupted access to oxygen and nutrients, the G-Rex® cell culture device is the only accessible cell expansion technology that linearly scales to meet the demands of cell therapy manufacturers.

Publications CAR T Cells G-Rex®24 Well Plate

Modular microfluidic device for intensified CAR T cell expansion

A compact perfused microfluidic culture device (µCCD) expanded primary T cells and anti-CD19 CAR T cells to much higher cell concentrations than a 24-well G-Rex® control, though with fewer total cells. Both systems were inoculated with one million cells, a density of 0.5 × 10⁶ cells per cm², and cultured for four days. CAR T cells reached 56.5 × 10⁶ viable cells per mL in the µCCD versus 3.14 × 10⁶ in the G-Rex®, with 14.1 × 10⁶ versus 25.1 × 10⁶ total viable cells. The µCCD consumed 46.8 mL of medium per device against 14 mL per G-Rex® well. Cytotoxicity against NALM6 targets was comparable, and µCCD cultures contained a higher proportion of central memory CD8 cells.

Download Now →

Author: Jorge Aranda Hernandez, Oleksandra Derevianko +6 more

Publications NKT Cells

Development of an efficient expansion protocol for human CD4- iNKT

Combining IL-15 with the G-Rex® bioreactor gives an efficient way to expand human CD4-negative invariant NKT cells from healthy donor blood. PBMC were cultured for 14 days with α-GalCer and one of IL-2, IL-4, IL-7 or IL-15; IL-15 added at day 0 produced the strongest expansion of total and subset-specific iNKT cells. G-Rex® cultures outperformed expansion bags at day 14 and raised the CD4-negative fraction, which stayed stable in bags. Expanded cells produced IFN-γ and IL-4, retained perforin and granzyme B, killed THP-1 leukemia cells and induced apoptosis in allogeneic dendritic cells. In irradiated NSG mice given human PBMC, co-transfer of expanded iNKT cells improved survival (p = 0.0…

Download Now →

Author: Jordan Brouard, Cristina Caraiman +2 more

Publications CAR T Cells G-Rex®6 Well Plate

In vitro efficacy of cell therapy products determined using a G-Rex® co-culture assay

A long-term co-culture killing assay in the G-Rex® 6 Well Plate lets researchers follow tumor cell growth and the effect of cell therapies without media changes. Target cells engineered to express firefly luciferase are seeded with D-luciferin, and bioluminescence, which tracks cell number linearly, is imaged repeatedly. Suspension lines (THP-1, Raji, Daudi) and a solid tumor line (PANC1) grew over several days in this format. In a demonstration, anti-CD19 CAR T cells controlled lymphoma growth, but a CD19-negative population emerged after three weeks of undisturbed culture. The suggested set-up uses 100 μM D-luciferin and 35 mL of medium per well, and the assay was also applied to non-en…

Download Now →

Author: Eric Smith, Andrew Lewis

Publications CAR T Cells G-Rex®100

Efficient CAR T cell manufacturing using a closed and integrated instrument workflow

A closed, integrated workflow linking the CTS DynaCellect, Rotea and Xenon systems produced gene-edited anti-CD19 CAR T cells from healthy-donor leukopaks with high viability. T cells isolated with CD3/CD28 magnetic beads were cultured for 3 days in OpTmizer Pro SFM with 100 U/mL IL-2, debeaded, washed on the Rotea system, and transferred through a welded PVC line to the Xenon system for Cas9 electroporation with a CD19 CAR DNA payload. On day 3 viability exceeded 90% and T cell content averaged 95%. After electroporation, viability averaged about 85% at day 10; about 25% and 30% of cells were CAR-positive without T cell receptor on days 3 and 10, and cultures expanded from about 10^8 to…